Sacubitril/Valsartan 2 mg | 99.94%
TargetMol
Sacubitril/Valsartan (LCZ696) is an orally bioavailable, dual angiotensin II receptor and neprilysin inhibitor for the treatment of hypertension and heart failure.
More Information Supplier Page
Sacubitril/Valsartan (LCZ696) is an orally bioavailable, dual angiotensin II receptor and neprilysin inhibitor for the treatment of hypertension and heart failure.
More Information Supplier Page
GSK-LSD1 2HCl is a specificity irreversible LSD1 inhibitor (IC50: 16 nM). The selectivity of GSK-LSD1 for LSD1 is >1000 fold over other closely related FAD utilizing enzymes (i.e. MAO-A, LSD2, MAO-B).
More Information Supplier Page
Isavuconazole(BAL-4815; RO-0094815) is the active component of the new azole antifungal agent BAL8557 with MIC(50)s/MIC(90)s ranged from 0.002/0.004 mg/liter for C. albicans to 0.25/0.5 mg/liter for C. glabrata.
More Information Supplier Page
ML204 is a novel potent antagonist that selectively modulates native TRPC4/C5 ion channels.
More Information Supplier Page
ML204 is a novel potent antagonist that selectively modulates native TRPC4/C5 ion channels.
More Information Supplier Page
ML204 is a novel potent antagonist that selectively modulates native TRPC4/C5 ion channels.
More Information Supplier Page
Articaine hydrochloride (Hoe-045) is a thiophene-containing local anesthetic pharmacologically similar to MEPIVACAINE.
More Information Supplier Page
AEE788 has been used in trials studying the treatment of Cancer, Glioblastoma Multiforme, and Brain and Central Nervous System Tumors.
More Information Supplier Page